Use access key #2 to skip to page content.
$9.53 0.06 (0.63%)
12/4/2008 12:55 PM

PDL BioPharma, Inc. (PDLI)

CAPS Rating:
****

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.

View All Commentary (PDLI)

Recs

0

Avatar jumperky (27.92) Submitted: 5/13/08 1:35 PM : Outperform Start Price: $9.42 PDLI Score: 41.81

Takeover target?

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links